57 citations as recorded by crossref.

1. Global practice variation of suppressive antimicrobial treatment for prosthetic joint infections: A cross-sectional survey study J. Hanssen et al. https://doi.org/10.1016/j.jinf.2024.106316
2. Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections G. Ceccarelli et al. https://doi.org/10.3390/antibiotics12050937
3. Candida periprosthetic infection of the hip: a systematic review of surgical treatments and clinical outcomes F. Fusini et al. https://doi.org/10.1007/s00264-019-04369-z
4. Development and Validation of Case‐Finding Algorithms to Identify Periprosthetic Joint Infections After Total Hip Arthroplasty in Veterans Health Administration Data J. O'Neil et al. https://doi.org/10.1002/pds.70311
5. Proactive Therapeutic Drug MONiToring to Guide Suppressive Antibiotic Therapy with DALBAvaNcin ( > 12 weeks) in Osteoarticular Infections (MONTALBANO) C. Mariani et al. https://doi.org/10.5194/jbji-10-255-2025
6. Suppressive antibiotic therapy in prosthetic joint infections: a multicentre cohort study R. Escudero-Sanchez et al. https://doi.org/10.1016/j.cmi.2019.09.007
7. Predictors of Success With Chronic Antibiotic Suppression for Prosthetic Joint Infections R. Burr et al. https://doi.org/10.1016/j.arth.2022.02.003
8. 2025 ICM: Antimicrobial Therapy Options in Special Circumstances M. Karim et al. https://doi.org/10.1016/j.arth.2025.10.084
9. Adverse events and tolerability of long-term suppressive antibiotic therapy for periprosthetic joint infection: a prospective cohort study P. Reinecke et al. https://doi.org/10.5194/jbji-11-267-2026
10. Long-term antimicrobial suppression prevents treatment failure of streptococcal periprosthetic joint infection N. Renz et al. https://doi.org/10.1016/j.jinf.2019.06.015
11. Risikofaktoren und Managementstrategien des Früh- und Spätinfektes nach Rekonstruktion mit Tumorspezialendoprothesen V. Janz et al. https://doi.org/10.1007/s00132-020-03872-1
12. Candida periprosthetic infection of the knee: a systematic review of surgical treatments and clinical outcomes F. Fusini et al. https://doi.org/10.1007/s00590-022-03224-z
13. Predicting Success of Two-Stage Exchange for Prosthetic Joint Infection Using C-Reactive Protein/Albumin Ratio C. Hong et al. https://doi.org/10.1155/2019/6521941
14. The efficacy of suppressive antibiotic treatment in patients managed non-operatively for periprosthetic joint infection and a draining sinus K. Lensen et al. https://doi.org/10.5194/jbji-6-313-2021
15. Peri-Prosthetic Joint Infection in Patients Prescribed Suppressive Antibiotic Therapy Undergoing Primary Total Joint Arthroplasty: A 1:4 Case Control Matched Study T. Humphrey et al. https://doi.org/10.1089/sur.2022.261
16. Prosthetic Joint Infection in Mega-Arthroplasty Following Shoulder, Hip and Knee Malignancy—A Prospective Follow-Up Study T. Khakzad et al. https://doi.org/10.3390/life12122134
17. Show Me the “Mino:” In Vitro Efficacy of Minocycline on Clinical Gram-Negative Bacterial Isolates P. Crowley et al. https://doi.org/10.1177/10766294261424485
18. Prolonged suppressive antibiotic therapy is successful in the management of prosthetic joint infection N. Sandiford et al. https://doi.org/10.1007/s00590-019-02559-4
19. Genomic characterization of beta‐haemolytic streptococci isolated from prosthetic joint infections N. Löwbeer et al. https://doi.org/10.1111/apm.13299
20. Dosing and treatment duration of suppressive antimicrobial therapy in orthopedic implant infections: a cohort study J. Hanssen et al. https://doi.org/10.5194/jbji-9-149-2024
21. Self‐Resolution of a Draining Sinus Tract in a Patient with Chronic Periprosthetic Hip Infection T. Shelton et al. https://doi.org/10.1155/2018/8657562
22. Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review P. Laffont-Lozes et al. https://doi.org/10.1007/s40121-026-01324-5
23. Unraveling the Challenges: A Compelling Case of Staph Meningitis and Graft Infection in a Bovine Brain Graft Recipient S. Ahmed et al. https://doi.org/10.7759/cureus.64806
24. Dalbavancin as suppressive antibiotic therapy in patients with prosthetic infections: efficacy and safety A. Ruiz-Sancho et al. https://doi.org/10.3389/fphar.2023.1185602
25. Orthopaedic Implant-Associated Staphylococcal Infections: A Critical Reappraisal of Unmet Clinical Needs Associated with the Implementation of the Best Antibiotic Choice M. Gatti et al. https://doi.org/10.3390/antibiotics11030406
26. Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach T. Ferry et al. https://doi.org/10.1051/sicotj/2020021
27. Oral tetracyclines for bone and joint infections: what do we know? T. Cartau et al. https://doi.org/10.5194/jbji-10-143-2025
28. Pharmacotherapy options and drug development in managing periprosthetic joint infections in the elderly A. Macias-Valcayo et al. https://doi.org/10.1080/14656566.2019.1602118
29. Résultats de l’intervention de Girdlestone pour le traitement de l’infection réfractaire sur prothèse de hanche A. Sabelle et al. https://doi.org/10.1016/j.rcot.2025.06.003
30. Suppressive Antibiotic Therapy After Debridement, Antibiotics, and Implant Retention is Well-Tolerated Without Inducing Resistance: A Multicenter Study S. Nandi et al. https://doi.org/10.1016/j.arth.2023.09.004
31. Research progress of asymptomatic bacteriuria before arthroplasty Q. Zhang et al. https://doi.org/10.1097/MD.0000000000009810
32. Chronic prosthetic joint infections with a draining sinus. Who should receive suppressive antibiotic treatment? K. Lensen et al. https://doi.org/10.5194/jbji-6-43-2020
33. Salvage-Optionen bei persistierendem Infekt nach Knietotalendoprothese E. Röhner & G. Matziolis https://doi.org/10.1007/s43205-021-00121-z
34. Is there a place for oral antibiotics in treating prosthetic joint infections in patients in whom surgery is contraindicated? M. Downs et al. https://doi.org/10.1097/EBP.0000000000000996
35. Past and Future of Phage Therapy and Phage-Derived Proteins in Patients with Bone and Joint Infection T. Ferry et al. https://doi.org/10.3390/v13122414
36. Outcomes of Long-Term Antibiotic Therapy for Prosthetic Joint Infection: A Cohort Study in a Canadian High-Volume Arthroplasty Center C. Righolt et al. https://doi.org/10.1016/j.artd.2025.101789
37. Arthroscopic “Debridement and Implant Retention” With Local Administration of Exebacase (Lysin CF-301) Followed by Suppressive Tedizolid as Salvage Therapy in Elderly Patients for Relapsing Multidrug-Resistant S. epidermidis Prosthetic Knee Infection T. Ferry et al. https://doi.org/10.3389/fmed.2021.550853
38. Clinical use of linezolid in periprosthetic joint infections – a systematic review C. Theil et al. https://doi.org/10.5194/jbji-6-7-2020
39. Long-Term Impact of Suppressive Antibiotic Therapy on Intestinal Microbiota R. Escudero-Sánchez et al. https://doi.org/10.3390/genes12010041
40. Contemporary Prosthetic Joint Infection Management: Is There a Role for Suppressive Antibiotic Therapy? N. Sandiford & D. Kendoff https://doi.org/10.1016/j.artd.2021.06.012
41. Periprosthetic Joint Infection R. Miller et al. https://doi.org/10.2106/JBJS.RVW.19.00224
42. How to manage treatment failure in prosthetic joint infection T. Peel & R. de Steiger https://doi.org/10.1016/j.cmi.2020.06.022
43. Debridement, antibiotics and implant retention: are all approaches to periprosthetic joint infection equal? Same procedures, different outcomes P. Sendi et al. https://doi.org/10.1016/j.cmi.2025.04.037
44. Adverse Events Associated with Prolonged Antibiotic Therapy for Periprosthetic Joint Infections—A Prospective Study with a Special Focus on Rifampin P. Reinecke et al. https://doi.org/10.3390/antibiotics12111560
45. Suppressive Antibiotic Therapy in Prosthetic Joint Infections: A Contemporary Overview H. Harrabi et al. https://doi.org/10.3390/antibiotics14030277
46. One-Stage Implant-Retaining Revision for Simultaneous Bilateral Infected Total Knee Arthroplasty: A Report of a Rare Case N. Wirries et al. https://doi.org/10.1155/2021/8846198
47. The Sinus Tract in Bone and Joint Infection: Minimally Invasive Salvation or Prolonged Suffering? A Multicenter Study S. Klim et al. https://doi.org/10.3390/jpm13050737
48. Complications of Hip Hemiarthroplasty G. Domingue et al. https://doi.org/10.3928/01477447-20230125-06
49. Surgical strategies for management of infection following knee arthroplasty and arthroscopic procedures A. Alvand et al. https://doi.org/10.1016/j.mporth.2019.03.003
50. Suppressive Antibiotic Treatment in Prosthetic Joint Infections: A Perspective J. Cobo & R. Escudero-Sanchez https://doi.org/10.3390/antibiotics10060743
51. Current Insights in the Evaluation and Treatment of Infected Total Knee Arthroplasty B. Ashley & J. Parvizi https://doi.org/10.1055/s-0041-1737030
52. Proceedings from the 2018 International Consensus Meeting on Orthopedic Infections: management of periprosthetic shoulder infection G. Garrigues et al. https://doi.org/10.1016/j.jse.2019.04.015
53. Infected total hip replacements: assessment and management H. Matar et al. https://doi.org/10.12968/hmed.2018.79.5.265
54. Clinical Outcome of Antibiotic Suppressive Therapy in Patients with a Prosthetic Joint Infection after Hip Replacement B. Leijtens et al. https://doi.org/10.7150/jbji.37262
55. The Use of Long-term Antibiotics for Suppression of Bacterial Infections M. Horne et al. https://doi.org/10.1093/cid/ciae302
56. Infección nosocomial en el área quirúrgica M. Corbacho-Loarte et al. https://doi.org/10.1016/j.med.2026.04.020
57. Results of the Girdlestone Procedure for the Treatment of Refractory Hip Prosthesis Infections A. Sabelle et al. https://doi.org/10.1016/j.otsr.2025.104313